Cytogenetic and molecular characterization of plutonium-induced rat osteosarcomas

Journal of Radiation Research

Volumn 51, Issue 3, 2010, Pages 243-250

  Roch Lefevre, Sandrine ^a,b   Daino, Kazuhiro ^a,c   Altmeyer Morel, Sandrine ^a   Guilly, Marie Noëlle ^a   Chevillard, Sylvie ^a  

^a INSTITUT DE RADIOBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Alpha particle emitter; Chromosome aberrations; Ionizing radiation; Osteosarcoma

Indexed keywords

GENE EXPRESSION; PLUTONIUM; RADIATION SHIELDING; RATS; TUMORS;

ALPHA-PARTICLE EMITTER; CHROMOSOMAL ABERRATION; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATIONS; COPY NUMBER; MOLECULAR CHARACTERIZATION; MOLECULAR EVENTS; OSTEOSARCOMAS; RADIATION-INDUCED; TARGET GENES;

IONIZING RADIATION;

RATTUS;

PLUTONIUM;

ANIMAL; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; GENE DOSAGE; GENETICS; IONIZING RADIATION; MALE; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; RADIATION INDUCED NEOPLASM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; MALE; NEOPLASMS, RADIATION-INDUCED; OSTEOSARCOMA; PLUTONIUM; RADIATION, IONIZING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954003512     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.09110     Document Type: Article

References (46)

1. Herzog CE (2005) Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol 27: 215-218.
2. Wong FL, et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. Jama 278: 1262-1267.
3. Patel SR (2000) Radiation-induced sarcoma. Curr Treat Options Oncol 1: 258-261.
4. Koshy M, et al (2005) Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys 63: 1169-1174.
5. Rowland RE, Stehney AF and Lucas HF Jr. (1978) Dose-response relationships for female radium dial workers. Radiat Res 76: 368-383.
6. Koshurnikova NA, et al (2000) Bone cancers in Mayak workers. Radiat Res 154: 237-245.
7. Nekolla EA, et al (2000) Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry. Radiat Res 153: 93-103.
8. Helman LJ and Meltzer P (2003) Mechanisms of sarcoma development. Nat Rev Cancer 3: 685-694.
9. Chauveinc L, et al (1999) Cytogenetic study of eight new cases of radiation-induced solid tumors. Cancer genetics and cytogenetics 114: 1-8.
10. Mertens F, et al (2000) Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p. Cancer genetics and cytogenet-ics 116: 89-96.
11. Lefevre SH, et al (2001) Genome instability in secondary solid tumors developing after radiotherapy of bilateral retino-blastoma. Oncogene 20: 8092-8099.
12. Tarkkanen M, et al (2001) Comparative genomic hybridization of postirradiation sarcomas. Cancer 92: 1992-1998.
13. Sandberg AA (2002) Cytogenetics and molecular genetics of bone and soft-tissue tumors. Am J Med Genet 115: 189-193.
14. Wunder JS, et al (1991) Analysis of alterations in the retinoblas-toma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 83: 194-200.
15. Wadayama B, et al (1994) Mutation spectrum of the retino-blastoma gene in osteosarcomas. Cancer Res 54: 3042-3048.
16. Belchis DA, et al (1996) Loss of heterozygosity and microsat-ellite instability at the retinoblastoma locus in osteosarcomas. Diagn Mol Pathol 5: 214-219.
17. Maelandsmo GM, et al (1995) Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 72: 393-398.
18. Kanoe H, et al (1998) Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Anticancer Res 18: 2317-2321.
19. Maitra A, et al (2001) Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer 95: 34-38.
20. Park YB, et al (2002) Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet 133: 105-111.
21. Lonardo F, et al (1997) P53 and MDM2 alterations in osteosa-rcomas: correlation with clinicopathologic features and prolif-erative rate. Cancer 79: 1541-1547.
22. Miller CW, et al (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950-7954.
23. Smith-Sorensen B, et al (1993) Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophore-sis (CDGE). Hum Mutat 2: 274-285.
24. Porter DE, et al (1992) A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg Br 74: 883-886.
25. Kloen P, et al (1997) Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression. Cancer 80: 2230-2239.
26. Burrow S, et al (1998) Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma. J Surg Oncol 69: 21-27.
27. Sulzbacher I, et al (2000) Platelet-derived growth factor-AA and-alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma. Mod Pathol 13: 632-637.
28. Lloyd RD, et al (1997) Bone tumor location in dogs given skeletal irradiation by 239Pu or 226Ra. Health Phys 73: 684-689.
29. Oghiso Y and Yamada Y (2003) The specific induction of osteosarcomas in different mouse strains after injections of 239Pu citrate. J Radiat Res (Tokyo) 44: 125-132.
30. Daino K, et al (2009) Gene expression profiling of alpha-radiation-induced rat osteosarcomas: Identification of dysregu-lated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer 125: 612-620.
31. Wong G and Cohn DV (1974) Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cells. Nature 252: 713-715.
32. Dano L, et al (2000) CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer 29: 1-8.
33. Petitot F, et al (2003) In vitro aging of rat lung cells. Down-regulation of telomerase activity and continuous decrease of telomere length are not incompatible with malignant transformation. Exp Cell Res 286: 30-39.
34. Vandesompele J, et al (2002) Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
35. Evron E, et al (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hyper-methylation. Cancer Res 61: 2782-2787.
36. Yu J, et al (2003) Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. Br J Cancer 88: 1560-1565.
37. Hattinger CM, et al (2004) Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol 83: 483-491.
38. Atiye J, et al (2005) Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42: 158-163.
39. Ladanyi M, et al (1993) Sporadic amplification of the MYC gene in human osteosarcomas. Diagn Mol Pathol 2: 163-167.
40. Hatada I, et al (1996) Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5: 783-788.
41. Shin JY, et al (2000) Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp Mol Med 32: 79-83.
42. Hoffmann MJ, et al (2005) Multiple mechanisms downregu-late CDKN1C in human bladder cancer. Int J Cancer 114: 406-413.
43. Szymanska K and Hainaut P (2003) TP53 and mutations in human cancer. Acta biochim Polon 50: 231-238.
44. Guimaraes DP and Hainaut P (2002) TP53: a key gene in human cancer. Biochimie 84: 83-93.
45. Gonin-Laurent N, et al (2006) Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis 27: 1266-1272.
46. Ramounet B and Fritsch P (1998) The distribution of plutonium between the mineral and organic components of rat bone: a biochemical study after in vivo and in vitro contamination. Int J Radiat Biol 73: 83-88.